TORONTO--(BUSINESS WIRE)--$KONEF #psychedelics--The Women in Psychedelics Network (“WIPN” or “Network”), a network of professionals from all corners of the psychedelic industry strengthening women’s voices and providing opportunities to move men
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological
--Company also strengthens Board of Directors with appointments of Luca Santarelli and Michael Tomsicek-- BASEL, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies,
MIAMI--(BUSINESS WIRE)--#Acquisition--H.I.G. Capital (“H.I.G.”), a leading global investment firm with $52 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the acquisition of Celerion Holdings
LAU-7b first inflammation-controlling drug to demonstrate clinical benefit in adults with CF, complementary to administration of CFTR modulators Study achieves clinically meaningful reduction in lung function loss at 6 months, measured as absolute chang
Real Estate Industry Has Raised over $42M for Cancer Research TORONTO--(BUSINESS WIRE)--Breaking all previous records, Hold’em For Life officially raised over $3 Million at the recent annual Real Estate Charity Challenge. As the biggest turnout ever, t
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to announce its participation in the following upcoming
Net revenue of $55.8 million for Q3 2022; including $30.0 million milestone from Otsuka related to European Approval of LUPKYNIS® (voclosporin) Adjusts net product revenue guidance to $100-105 million from sales of LUPKYNIS for 2022 Issues preliminary
Nutrien revised full-year 2022 earnings guidance to reflect lower near-term potash sales volumes and prices; continue to advance strategic growth initiatives based on a positive multi-year view of the fundamentals. SASKATOON, Saskatchewan--(BUSINESS WIRE
VANCOUVER, British Columbia--(BUSINESS WIRE)--#Veterans--REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist'' or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), releases proprietary supplement lines to extend the results of psychedelic me
BAM's 2023 Most Promising Bioscience Student, Daniel Gussakovsky, and recent scholarship winner, shares about his research, why he's chosen it, and what he hopes to do in the future with it.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.